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Sistemic lupus erythematosus is an autoimmune disease, which can affect a lot of organs, including 
lungs. 
 
The aim:  
The aim of this study was to investigate the frequency of lung involvement in patients with Systemic 
Lupus Erythematosus (SLE) treated at the Military Medical Academy. 
Material and methods: 75 patients (68; 90.6% female) were included in this cross-sectional study. 
They all met the revised EULAR/ACR classification criteria for SLE. The mean age was 45 ± 12 (22-
78) years. The disease lasted an average of 11 ± 10 (1-38) years. In all patients, the presence of 
symptoms and signs of lung disease, radiographic examination of the lungs, spirometry and carbon 
monoxide lung factor transfer (DLCO). 
 
Results:  
At the time of the trial, two patients had clinically manifest lung disease. Also, one had changes in the 
lung radiography (bilateral fibrosis). Normal spirometry was reported by  67 (89,37%) patients, 
ventilation disturbances of restriction type light grade 3(4%), moderate-severe degree 4 (5,3%) and 
severe degree 1 (1.33%). Normal DLCO had 19 (25,33%), decreased mild grade 35 (46,67%), 
moderately-severe 17 (22,67%) and severe grade 4 (5,33%) patients. None of the patients with normal 
spirometry and reduced DLCO had any clinical or radiographic signs of lung disease. 
 
Conclusion:  
Our study showed that a significant number of patients without clinically and radiographically manifest 
lung disease and with normal spirographic findings, had a reduced DLCO. Based on these results, we 
believe that patients with SLE without respiratory symptoms should be monitored pulmonary function 
(DLCO) periodically for possible development of interstitial lung disease with subsequent pulmonary 
hypertension.  
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